Steven Shallcross, CEO and CFO, Director at Synthetic Biologics, holds 50.00K shares in Synthetic Biologics (Ticker: SYN), holds ― shares in Elys Game Technology (Ticker: ELYS), holds 0.00 shares in Vanda (Ticker: VNDA). Most recently, Steven Shallcross Bought ― shares of Synthetic Biologics on Aug 26, 2019 for an estimated value of 20.50K.